LEVERAGE SHORT - PFIZER INC | Market Closed - BME 11:30:00 2024-05-03 EDT | ||
| 7.89 EUR | -16.33% |
|
| Current month | -63.79% | ||
| 1 month | -43.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 7.89 | -16.33% | 0 |
| 24-05-02 | 9.43 | -56.72% | 0 |
| 24-04-30 | 21.79 | +2.78% | 0 |
| 24-04-29 | 21.2 | -11.33% | 0 |
| 24-04-26 | 23.91 | +3.42% | 0 |
Delayed Quote BME
Last update May 03, 2024 at 11:30 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| Z1109 | |
| ISIN | DE000SN2BL85 |
| Date issued | 2021-05-27 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 5.05 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 38.15 € |
|---|---|
| Lowest since issue | 0.79 € |
| Spread | 0.03 € |
| Spread % | 0.38% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.81
USD
Average target price
31.89
USD
Spread / Average Target
+14.68%
- Stock Market
- Certificates
- Z1109 Certificat
